Answers are grounded in this paper and cite their sources.
Fisetin, a polyphenolic compound derived from Venetian sumach (Rhus cotinus L.), exhibits notable antioxidant, neuroprotective, anti-inflammatory, and senolytic effects. The compound Fisetin is a secondary metabolite. Chemically, it is known as 2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-4H-1-benzopyran-4-one, 3,3′,4′,7-tetrahydroxyflavone, or 5-deoxy quercetin. Presently, it is obtained from various plants. This bioactive molecule is also reported to exhibit anticancer potential, and researchers have shown promising activity in the management of various cancers, including oral, breast, lung, and brain cancers, as well as other malignancies. Despite holding significant promise, as with other natural compounds, this molecule is associated with challenges such as poor aqueous solubility, compromised bioavailability, greater lipophilicity, and uneven pharmacokinetic distribution. This review highlights the research-based evidence for Fisetin in cancer treatment and emphasizes nanotechnology-based approaches employing this bioactive molecule across various cancers. Examining fisetin’s clinical trials helps chart its evolution from a dietary supplement to a promising anticancer drug.
No takes yet. Share an insight, caveat, or question.
Barkat et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: